Sotera Health Company
SHC
$11.06
-$0.13-1.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.11B | 1.10B | 1.12B | 1.10B | 1.08B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.11B | 1.10B | 1.12B | 1.10B | 1.08B |
| Cost of Revenue | 496.18M | 498.15M | 502.46M | 492.21M | 484.10M |
| Gross Profit | 610.61M | 602.30M | 618.01M | 605.97M | 592.77M |
| SG&A Expenses | 203.44M | 204.75M | 202.29M | 194.29M | 190.23M |
| Depreciation & Amortization | 61.63M | 62.04M | 62.36M | 62.62M | 63.30M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 761.25M | 764.93M | 767.12M | 749.12M | 737.64M |
| Operating Income | 345.54M | 335.51M | 353.36M | 349.06M | 339.24M |
| Income Before Tax | 88.04M | 113.87M | 134.58M | 92.30M | 111.64M |
| Income Tax Expenses | 63.22M | 69.48M | 63.82M | 52.20M | 56.78M |
| Earnings from Continuing Operations | 24.82 | 44.40 | 70.76 | 40.10 | 54.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.82M | 44.40M | 70.76M | 40.10M | 54.86M |
| EBIT | 345.54M | 335.51M | 353.36M | 349.06M | 339.24M |
| EBITDA | 512.12M | 501.78M | 520.05M | 510.79M | 500.54M |
| EPS Basic | 0.09 | 0.16 | 0.25 | 0.14 | 0.19 |
| Normalized Basic EPS | 0.40 | 0.38 | 0.42 | 0.41 | 0.41 |
| EPS Diluted | 0.08 | 0.15 | 0.25 | 0.14 | 0.19 |
| Normalized Diluted EPS | 0.40 | 0.37 | 0.42 | 0.41 | 0.41 |
| Average Basic Shares Outstanding | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B |
| Average Diluted Shares Outstanding | 1.14B | 1.14B | 1.14B | 1.13B | 1.13B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |